Clinical trial

Study of Motesanib (AMG 706) in Combination With Paclitaxel and Carboplatin for Advanced Non-Squamous Non-Small Cell Lung Cancer

NCT02629848

StatusTERMINATED

Study typeINTERVENTIONAL

Start date2012-07-01

PhasePHASE3

Study timeline

Study start (unknown)2012-07-01Date precision: month

Registry last updated2015-12-14

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Carcinoma, Non-Small-Cell Lungunresolved

Interventions

MotesanibDRUG

PlaceboDRUG

PaclitaxelDRUG · verified · RxNorm: paclitaxel

CarboplatinDRUG · verified · RxNorm: carboplatin

Sponsors & collaborators

Takedalead sponsor

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT02629848 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.